Practice implications and recommendations for managing codeine misuse and dependence

Open access


Codeine, a weak opiate, requires increased pharmacovigilance relating to availability, heterogeneous nature of misuse, dependence and associated harm. A scoping review of literature on codeine was conducted using Arksey & O’Malley’s framework (1). Databases searched included PubMed, EBSCO Host, Science Direct, EMBASE, PsycINFO, Cochrane library and Medline from 1994 to 2014. Follow-up search strategies involved hand searching and searching of pharmaceutical, health, medical and drug related websites. Initial zscreening identified 3,105 articles with 475 meeting the inclusion criteria. Eight broad categories organised the literature, data charting and qualitative synthesis. This paper presents implications for practice and makes recommendations to address these issues. Themes identified relate to raising public and practitioner awareness, risk management, dispensing practices and monitoring and surveillance of codeine. Evidence to inform law enforcement, drug surveillance, public health initiatives, harm reduction approaches, pharmacy, clinical and treatment practices is warranted.

1. H. Arksey and L. O’Malley, Scoping studies: towards a methodological framework, Int. J. Soc. Res. Method. 8 (2005) 19-32.

2. S. Derry, R. A. Moore and H. McQuay, Single dose oral codeine, as a single agent, for acute postoperative pain in adults, Cochrane Database System Rev. 4 (2010) CD008099; DOI: 10.1002/14651858. CD008099.pub2.

3. European Medicines Agency, Assessment Report for Codeine-containing Medicinal Products Indicated in the Management of Pain in Children. Procedure under Article 31 of Directive 2001/83/EC resulting from pharmacovigilance data. Procedure number: EMEA/H/A-31/1342, Assessment 24 June 2013 EMA/441891/2013, London;; last access August 2, 2015.

4. International Narcotics Control Board, Narcotic Drugs, Estimated World Requirements for 2012, Statistics for 2010, United Nations, New York, 2012;; last access August 2, 2015.

5. M. Van Hout, M. Bergin, M. Foley, E. Rich, A. I. Rapca, R. Harris and I. Norman, A Scoping Review of Codeine Use, Misuse and Dependence. Final Report CODEMISUSED Project European Commission 7th Framework Programme, Brussels 2014.

6. S. A. Francis, N. Barnett and M. Denham, Switching of prescription drugs to over-the-counter status: is it a good thing for the elderly? Drugs Aging 22 (2005) 361-370; DOI: 10.2165/00002512-200522050-00001.

7. A. Casati, R. Sedefov and T. Pfeiffer-Gerschel, Misuse of medicines in the European Union: A systematic review of the literature, Eur. Addict. Res. 18 (2012) 228-245; DOI: 10.1159/000337028.

8. K. H. Wang, W. Becker and D. A. Fiellin, Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents, Drug Alc. Depend. 127 (2013) 156-162; DOI: 10.1016/j. drugalcdep.2012.06.027.

9. M. C. Van Hout, Kitchen chemistry: A scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions, Drug Test. Anal. 6 (2014) 778-787; DOI: 10.1002/dta.1622.

10. G. M. Peterson, Selecting nonprescription analgesics, Am. J. Ther. 12 (2005) 67-79.

11. B. A. Sproule, U. E. Busto, G. Somer, M. K. Romach and E. M. Sellers, Characteristics of dependent and nondependent regular users of codeine, J. Clin. Psychopharmacol. 19 (1999) 367-372.

12. M. Y. Frei, S. Nielsen, M. D. Dobbin and C. L. Tobin, Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases, Med. J. Aus. 193 (2010) 294-296.

13. G. Robinson, S. Robinson, P. McCarthy and C. Cameron, Misuse of over-the-counter codeinecontaining analgesics: dependence and other adverse effects, N. Z. Med. J. 123 (2010) 59-64.

14. S. Nielsen, J. Cameron and S. Pahoki, Over the Counter Codeine Dependence, Turning Point Drug and Alcohol Centre, Victorian Department of Health, Melbourne, 2010;; last access September 30, 2015.

15. S. Nielsen, R. Bruno, S. Carruthers, J. Fischer, N. Lintzeris and M. Stoove, Investigation of Pharmaceutical Misuse Amongst Drug Treatment Clients, Turning Point Drug and Alcohol Centre, Victorian Department of Health, Melbourne 2008;; last access September 30, 2015.

16. R. Cooper, ‘I can’t be an addict. I am.’ Over-the-counter medicine abuse: a qualitative study, BMJ Open 3 (2013) e002913; DOI: 10.1136/bmjopen-2013-002913.

17. S. E. McCabe, J. A. Cranford, C. J. Boyd and C. J. Teter, Motives, diversion and routes of administration associated with nonmedical use of prescription opioids, Addict. Behav. 32 (2007) 562-575; DOI: 10.1016%2Fj.addbeh.2006.05.022.

18. S. E. McCabe, C. J. Boyd and C. J. Teter, Subtypes of nonmedical prescription drug misuse, Drug Alcohol Depend. 102 (2009) 63-70; DOI: 10.1016/j.drugalcdep.2009.01.007.

19. G. Reay, An Inquiry into Physical Dependence and Addiction to Prescription and Over-the-counter Medication, The All-party parliamentary drugs misuse group, 2007-2008 Parliamentary session, London 2008;; last access September 30, 2015.

20. M. Dobbin and C. Tobin, Over-the-counter Ibuprofen/Codeine Analgesics: Misuse and Harm, Victorian Drugs Policy and Services Branch, Department of Human Services, Melbourne 2008.

21. K. Reed, A. Bond, J. Witton, R. Cornish, M. Hickman and J. Strang, The Changing Use of Prescribed Benzodiazepines and Z-drugs and of Over-the-counter Codeine-containing Products in England: a Structured Review of Published English and International Evidence and Available Data to Inform Consideration of the Extent of Dependence and Harm, The National Addiction Centre, Kings College London and School of Social and Community Medicine, University of Bristol, Bristol 2011;; last access September 27, 2015.

22. R. J. Cooper, Respectable Addiction - a Qualitative Study of Over the Counter Medicine Abuse in the UK, School of Health and Related Research (ScHARR), University of Sheffield. Sheffield 2011; http://; last access October 1, 2015.

23. A. M. Hamer, J. M. Spark, P. J. Wood and E. Roberts, The upscheduling of combination analgesics containing codeine: The impact on the practice of pharmacists, Res. Soc. Admin. Pharm. 10 (2014) 669-678; DOI: 10.1016/j.sapharm.2013.08.004

24. F. L. Shand, G. Campbell, W. Hall, N. Lintzeris, M. Cohen and L. Degenhardt, Real-time monitoring of Schedule 8 medicines in Australia: evaluation is essential, Med. J. Aus. 198 (2013) 80-81; DOI: 10.5694/mja12.10785.

25. B. McAvoy, M. Dobbin and C. Tobin, Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand, New Zeal. Med. J. 124 (2011) 29-33.

26. C. Tobin, M. Dobbin and B. McAvoy, Regulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom, Aust. New Zeal. J. Pub. Health 37 (2013) 483-488; DOI: 10.1111/1753-6405.12099.

27. H. M. L. Daudt, C. van Mossel and S. J. Scott, Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework, Med. Res. Method. 13 (2013) 48; DOI: 10.1186/1471-2288-13-48.

28. C. L. Roumie and M. R. Griffin, Over-the-counter analgesics in older adults: a call for improved labelling and consumer education, Drugs Aging 21 (2004) 485-498.

29. G. C. Alexander, N. Mohajir and D. O. Meltzer, Consumers’ perceptions about risk of and access to nonprescription medications, Am. Pharm. Assoc. 45 (2005) 363-370; DOI: 10.1331/1544345054003868.

30. M. Wazaify, E. Shields, C. M. Hughes and J. C. McElnay, Societal perspectives on over-the-counter (over the counter) medicines, Fam. Pract. 22 (2005) 170-176; DOI: 10.1093/fampra/cmh723.

31. L. A. Hanna and C. M. Hughes, ‘First, do no harm’: factors that influence pharmacists making decisions about over-the-counter medication: a qualitative study in Northern Ireland, Drug Saf. 33 (2010) 245-255; DOI: 10.2165/11319050-000000000-00000.

32. R. J. Cooper, Over-the-counter medicine abuse: a review of the literature, J. Subst. Use 18 (2013) 82-107; DOI: 10.3109/14659891.2011.615002.

33. M. Foley, R. Harris, E. Rich , A. Rapca, M. Bergin, I. Norman and M. C. Van Hout, The availability of over-the-counter codeine medicines across the European Union, Public Health (2015) in press; DOI: 10.1016/j.puhe.2015.06.014.

Acta Pharmaceutica

The Journal of Croatian Pharmaceutical Society

Journal Information

IMPACT FACTOR 2017: 1.071
5-year IMPACT FACTOR: 1.623

CiteScore 2017: 1.46

SCImago Journal Rank (SJR) 2017: 0.362
Source Normalized Impact per Paper (SNIP) 2017: 0.642

Cited By


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 378 378 65
PDF Downloads 203 203 34